Amicus Therapeutics (FOLD) Rides DMX-200 Progress and Bullish Coverage – Is Its Pipeline Undervalued? - simplywall.st

Amicus Therapeutics (FOLD) Rides DMX-200 Progress and Bullish Coverage – Is Its Pipeline Undervalued?  simplywall.st